Cancer miracle? The missing report.

[Guest guest]

Type into the Internet - www.ncbi.nlm.nih.gov/pubmed - and you will see these

words:

" PubMed is a service of the National Library of Medicine that includes over 15

million citations

from MEDLINE and other life science journals for biomedical articles back to the

1950s... "

There is a missing report not to be found among the " 15 million citations " .

I want to focus upon two chemicals that have been integral to the cancer

research

of Dr. V. Schally, a 1977 Nobel Prize winner in Medicine -

A. TAC (Thiazolidine-4-carboxylic acid)

B. 2-pyrrolino-DOX (2-pyrrolinodoxorubicin).

(Verification of statements can be made by typing word combinations or numbers

into Medline.)

A. From 1994 to 2005, Dr. Schally published 18 laboratory reports which

revealed, in essence,

that compounds containing TAC might prove to be effective in causing the

" Inhibition of growth "

of most forms of human cancer. (Schally TAC)

B. From 1996 to 2005, Dr. Schally published 38 laboratory reports (Schally

2-pyrrolinodoxorubicin)

that revealed the anti-cancer effectiveness of 2-pyrrolino-DOX; indeed,

this compound appears

to be a phenomenon. In 1996, Dr. Schally published two reports (8637897 &

8692981) which revealed

that it is " 500-1000 times more potent " than Doxorubicin (DOX).

DOX, also known as Adriamycin and 'The Red Devil', is in " ...the class of

antitumor drugs with

the widest spectrum of activity in human cancers... " and " ...at present

(j.s.r. - 1992)

DOX still reigns in this drug class as the one having the most proven

cancerocidal effect. " (1462166)

Late in 1996, Dr. Schally combined TAC & 2-pyrrolino-DOX, and designated it

'AN-257' with which

he achieved miraculous laboratory results. The numbers following the cancers

indicate how many

" times higher " AN-257 was than DOX in causing the " Inhibition of growth " upon

" cancer cell lines " -

Pancreatic - 335

SCLC (Small Cell Lung Cancer) - 1657

Prostate - 224

Gastric (Stomach) - 857.

Everyone can see a citation to this research (It was published in January,

1997.) by typing

Thiazolidine-4-carboxylic acid 2-pyrrolinodoxorubicin into Medline.

I want everyone to note a oddity - Medline contains over 15 million citations;

this was the only article

ever published detailing the anti-cancer results obtained by combining these two

chemicals.

Evidently, Dr. Schally never published a report explaining why he chose not to

initiate a clinical trial

to determine what effect the combination of these two chemicals might have upon

cancer patients.

I call this " The missing report " .

S. , The Cure for Cancer? , http://cures for cancer.ws/tac-cure.htm

Post Script - Dr. Gosalvez, Director of Spanish Biochemical Research from

1970 to 2000,

says that TAC and Quelamycin (a form of Doxorubicin) were administered to

" terminal cancer patients "

in U.S. Military Hospitals from 1990 to 2000, and he thinks the procedure was a

success.

The procedure was instituted because of the influence of King of

Spain

and President Bush (41).